Breaking News Instant updates and real-time market news.

ORA

Ormat Technologies

$54.77

1.37 (2.57%)

06:35
11/06/18
11/06
06:35
11/06/18
06:35

Ormat Technologies reports Q3 adjusted EPS 31c, consensus 42c

Reports Q3 revenue $166.5M, consensus $172.97M.

  • 06

    Nov

ORA Ormat Technologies
$54.77

1.37 (2.57%)

06/13/18
06/13/18
DOWNGRADE

Neutral
Ormat downgraded to Neutral on poor visibility, Hawaii overhang at Guggenheim
As previously reported, Guggenheim analyst Sophie Karp downgraded Ormat Technologies to Neutral from Buy, citing poor visibility due to the pending 2017 results restatement and the ongoing internal controls issue. She also has revised her estimates to incorporate at least a temporary loss of the plant in Hawaii, which she sees continuing to create an overhang on the shares in the near-term.
08/09/18
JPMS
08/09/18
UPGRADE
Target $60
JPMS
Overweight
Ormat Technologies upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster upgraded Ormat Technologies to Overweight while lowering his price target for the shares to $60 from $64. The company reported mixed Q2 results and guidance owing to disruption at the Puna plant in Hawaii, Coster tells investors in a post-earnings research note. However, he believes that when excluding Puna, Ormat's execution "remains solid" and the company's long-term growth prospects "remain undimmed." He finds the stock attractively valued at current levels.
08/09/18
08/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ormat Technologies (ORA) upgraded to Overweight from Neutral at JPMorgan by analyst Paul Coster. The company reported mixed Q2 results and guidance owing to disruption at the Puna plant in Hawaii, but Coster believes that when excluding Puna, Ormat's execution "remains solid" and the company's long-term growth prospects "remain undimmed." 2. Wright Medical (WMGI) upgraded to Buy from Neutral at BofA/Merrill by analyst Travis Steed, who cited increased confidence in 2H 2018 and 2019 double digit growth and upside to Street estimates. Steed said growth in the core lower extremities business returned to market rates for the first time since Q1 2016 and believes it can accelerate further from new products and productivity ramps. 3. WildHorse Resource (WRD) upgraded to Buy from Hold at SunTrust by analyst Welles Fitzpatrick, who noted that the 13% decline in the stock price "makes little sense" from differentials or CapEx point of view, adding that the move in pricing does not warrant the large decline. Fitzpatrick views WildHorse Resource as a "simple, single-basin story, with distinct, quantifiable advantages such as premium oil pricing given its gulf coast access, ability to realized material savings with an in-field sand mine, and optionality to expand its midstream system." 4. ITG (ITG) upgraded to Overweight from Neutral at JPMorgan by analyst Kenneth Worthington, saying that the company's fundamentals are improving as it gains "traction on a number of fronts" that have and will continue to drive higher earnings power over time, particularly outside the U.S. 5. Comstock Resources (CRK) upgraded to Buy from Neutral at Ladenburg by analyst Michael Schmitz, who said the recent pullback in shares provides an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/17/18
OPCO
09/17/18
NO CHANGE
OPCO
Perform
Oppenheimer remains on sidelines on Ormat after meeting with VP of IR
Oppenheimer analyst Noah Kaye tells investors in a research note that he remains on the sidelines on Ormat Technologies after meeting with VP of Investor Relations Smadar Lavi for an update on key topics, telling investors in a research note that resolution of the Puna insurance claims could eliminate an overhang and possibly support multiple expansion.

TODAY'S FREE FLY STORIES

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

, BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

08:57
02/22/19
02/22
08:57
02/22/19
08:57
Conference/Events
Piper Jaffray biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

AVEO

Aveo Pharmaceuticals

$0.62

-0.0047 (-0.75%)

BMY

Bristol-Myers

$50.15

-1.14 (-2.22%)

EXEL

Exelixis

$21.22

(0.00%)

IMMU

Immunomedics

$14.33

-0.03 (-0.21%)

JNJ

Johnson & Johnson

$135.40

-0.91 (-0.67%)

MRK

Merck

$79.82

0.38 (0.48%)

NKTR

Nektar

$40.26

-2.76 (-6.42%)

PFE

Pfizer

$42.14

-0.07 (-0.17%)

SGEN

Seattle Genetics

$69.25

-0.53 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

  • 11

    Apr

  • 18

    May

  • 20

    May

  • 17

    Jun

TRIL

Trillium Therapeutics

$1.28

0.08 (6.67%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Hot Stocks
Breaking Hot Stocks news story on Trillium Therapeutics »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

GE

General Electric

$10.03

-0.07 (-0.69%)

, LLY

Eli Lilly

$122.72

0.05 (0.04%)

08:55
02/22/19
02/22
08:55
02/22/19
08:55
Options
Notable open interest changes for February 22nd »

Thursday's total…

GE

General Electric

$10.03

-0.07 (-0.69%)

LLY

Eli Lilly

$122.72

0.05 (0.04%)

TSLA

Tesla

$291.18

-11.33 (-3.75%)

ELAN

Elanco

$29.07

-0.29 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 27

    Feb

  • 18

    Mar

  • 19

    Mar

  • 18

    May

PLAN

Anaplan

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Anaplan analyst commentary  »

Anaplan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

ZG

Zillow

$35.07

0.22 (0.63%)

, Z

Zillow

$35.03

0.22 (0.63%)

08:54
02/22/19
02/22
08:54
02/22/19
08:54
Recommendations
Zillow, Zillow analyst commentary  »

Zillow core business…

ZG

Zillow

$35.07

0.22 (0.63%)

Z

Zillow

$35.03

0.22 (0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 11

    Mar

  • 25

    Mar

STM

STMicroelectronics

$16.55

(0.00%)

08:52
02/22/19
02/22
08:52
02/22/19
08:52
Initiation
STMicroelectronics initiated  »

Cowen initiates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GE

General Electric

$10.03

-0.07 (-0.69%)

08:51
02/22/19
02/22
08:51
02/22/19
08:51
Initiation
Wabtec, General Electric initiated  »

Wabtec initiated with a…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GE

General Electric

$10.03

-0.07 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

PNW

Pinnacle West

$92.01

1.095 (1.20%)

08:50
02/22/19
02/22
08:50
02/22/19
08:50
Earnings
Pinnacle West reaffirms FY19 EPS view $4.75-$4.95, consensus $4.85 »

Expects to achieve a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Mar

ENV

Envestnet

$55.50

-0.91 (-1.61%)

08:50
02/22/19
02/22
08:50
02/22/19
08:50
Recommendations
Envestnet analyst commentary  »

Envestnet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

ANIK

Anika Therapeutics

$40.45

0.45 (1.13%)

08:49
02/22/19
02/22
08:49
02/22/19
08:49
Downgrade
Anika Therapeutics rating change  »

Anika Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNW

Pinnacle West

$92.01

1.095 (1.20%)

08:49
02/22/19
02/22
08:49
02/22/19
08:49
Earnings
Pinnacle West reports Q4 EPS 23c, consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 04

    Mar

NDLS

Noodles & Company

$7.46

0.1 (1.36%)

08:49
02/22/19
02/22
08:49
02/22/19
08:49
Upgrade
Noodles & Company rating change  »

Jefferies upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ON

ON Semiconductor

08:48
02/22/19
02/22
08:48
02/22/19
08:48
Initiation
ON Semiconductor initiated  »

ON Semiconductor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 08

    May

ATR

AptarGroup

$103.17

1.05 (1.03%)

08:48
02/22/19
02/22
08:48
02/22/19
08:48
Downgrade
AptarGroup rating change  »

AptarGroup downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

VZ

Verizon

$56.14

0.35 (0.63%)

08:47
02/22/19
02/22
08:47
02/22/19
08:47
Recommendations
Verizon analyst commentary  »

Verizon has network focus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

  • 03

    Mar

  • 11

    Mar

WDAY

Workday

$189.36

0.66 (0.35%)

08:46
02/22/19
02/22
08:46
02/22/19
08:46
Recommendations
Workday analyst commentary  »

Workday price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

EXAS

Exact Sciences

$83.30

-0.3 (-0.36%)

08:46
02/22/19
02/22
08:46
02/22/19
08:46
Recommendations
Exact Sciences analyst commentary  »

Exact Sciences price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

COTY

Coty

$11.11

-0.04 (-0.36%)

, CMCSA

Comcast

$38.46

0.67 (1.77%)

08:45
02/22/19
02/22
08:45
02/22/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

COTY

Coty

$11.11

-0.04 (-0.36%)

CMCSA

Comcast

$38.46

0.67 (1.77%)

AXDX

Accelerate Diagnostics

$21.55

0.02 (0.09%)

SLB

Schlumberger

$44.73

-1.18 (-2.57%)

RSX

Market Vectors Russia ETF

$20.55

-0.16 (-0.77%)

UBS

UBS

$12.32

-0.13 (-1.04%)

NOK

Nokia

$6.15

0.055 (0.90%)

HEAR

Turtle Beach

$15.85

0.05 (0.32%)

ABB

ABB

$20.21

-0.04 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 11

    Mar

  • 13

    Mar

  • 18

    Apr

  • 22

    May

  • 23

    May

08:45
02/22/19
02/22
08:45
02/22/19
08:45
General news
Oil Action: WTI crude »

Oil Action: WTI crude…

08:45
02/22/19
02/22
08:45
02/22/19
08:45
General news
Action Economics has a new Podcast »

Action Economics has a…

PLNT

Planet Fitness

$58.26

-0.18 (-0.31%)

, AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

08:44
02/22/19
02/22
08:44
02/22/19
08:44
Upgrade
Planet Fitness a platform like Amazon, not a gym, Jefferies says in upgrade »

Jefferies analyst Randal…

PLNT

Planet Fitness

$58.26

-0.18 (-0.31%)

AMZN

Amazon.com

$1,619.84

-2.26 (-0.14%)

NFLX

Netflix

$356.74

-3.26 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 03

    Mar

  • 03

    Mar

  • 18

    Mar

XSPA

XpresSpa

$0.19

-0.0017 (-0.89%)

08:43
02/22/19
02/22
08:43
02/22/19
08:43
Hot Stocks
XpresSpa announces 1-for-20 reverse stock split »

XpresSpa announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HK

Halcon Resources

$1.79

-0.07 (-3.76%)

08:43
02/22/19
02/22
08:43
02/22/19
08:43
Downgrade
Halcon Resources rating change  »

Halcon Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

, XRX

Xerox

$31.34

0.47 (1.52%)

08:43
02/22/19
02/22
08:43
02/22/19
08:43
Periodicals
Breaking Periodicals news story on Caterpillar, Xerox »

Caterpillar, Xerox to be…

CAT

Caterpillar

$138.85

-1.44 (-1.03%)

XRX

Xerox

$31.34

0.47 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:42
02/22/19
02/22
08:42
02/22/19
08:42
Conference/Events
Federal Reserve Board Vice Chairman participates in a panel discussion »

Federal Reserve Board…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.